This study performed in vitro experiments to demonstrate that reducing E2F7 levels has anti-cancer effects on LUAD, achieved by hindering cell growth through the AKT/mTOR signaling pathway and increasing apoptosis signals. The gene discussed is AKT1; the disease is cancer.